As an antiplatelet drug, the use of clopidogrel bisulfate (Plavix) requires attention to individualized medication guided by genetic testing, standardized dosage regimens, and special precautions. The following provides a detailed explanation from three aspects: standard usage, necessity of genetic testing, and medication warnings.

1. Standard usage and dosage

(1) Acute coronary syndrome: loading dose 300-600mg, maintenance dose 75mg/day.

(2) Stroke prevention: 75mg once daily, requires long-term continuous use.

(3) Medication method: Tablets can be broken open and taken on an empty stomach or after meals.

2. Genetic testing requirements

(1) CYP2C19 slow metabolizer: Consider switching to prasugrel or ticagrelor.

(2) Intermediate metabolic type: The dose can be increased to 150mg/day, but bleeding needs to be closely monitored.

(3) Testing timing: It is recommended to complete genotype testing before medication.

3. Important precautions

(1) Bleeding risk: Avoid combination with NSAIDs and SSRIs, and elderly patients should monitor fecal occult blood.

(2) Surgical management: Discontinue medication 5-7 days before scheduled surgery, and emergency platelet transfusion is required for reversal.

(3) Omission treatment: Take the regular dose immediately and skip it when it is close to the next dose.